Literature DB >> 3783587

Selective monoamine oxidase inhibitors. 4. 4-Aminophenethylamine derivatives with neuron-selective action.

L Florvall, I Fagervall, A L Ask, S B Ross.   

Abstract

Nine 4-aminophenethylamine derivatives were synthesized and tested for monoamine oxidase (MAO) inhibitory effects with particular attention to their selectivity for MAO within monoaminergic neurons in the rat brain. All compounds selectively inhibited the A form of MAO in vitro. Some of the compounds inhibited the MAO within the monoaminergic neurons at much lower doses than those required for inhibition of MAO within other cells in vivo. The most potent compounds in this respect were 4-amino-2-fluoro-alpha-methylphenethylamine (5) and 4-amino-2-chloro-alpha-methylphenethylamine (4).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3783587     DOI: 10.1021/jm00161a020

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  4 in total

1.  Charge-transfer interactions in the inhibition of MAO-A by phenylisopropylamines--a QSAR study.

Authors:  Gabriel Vallejos; Marcos Caroli Rezende; Bruce K Cassels
Journal:  J Comput Aided Mol Des       Date:  2002-02       Impact factor: 3.686

2.  Selective inhibition by 4,alpha-dimethyl-m-tyramine (H77/77) and 4-methyl-alpha-ethyl-m-tyramine (H75/12) of the monoamine oxidase within serotonergic and noradrenergic neurons in the rat brain.

Authors:  I Fagervall; D Kelder; S B Ross
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-08       Impact factor: 3.000

3.  Release of 3H-5-hydroxytryptamine by amiflamine and related phenylalkylamines from rat occipital cortex slices.

Authors:  A L Ask; I Fagervall; R B Huang; S B Ross
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-06       Impact factor: 3.000

Review 4.  Amphetamine Derivatives as Monoamine Oxidase Inhibitors.

Authors:  Miguel Reyes-Parada; Patricio Iturriaga-Vasquez; Bruce K Cassels
Journal:  Front Pharmacol       Date:  2020-01-23       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.